A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114

TAS‐114 is a dual deoxyuridine triphosphatase (dUTPase) and dihydropyrimidine dehydrogenase (DPD) inhibitor expected to widen the therapeutic index of capecitabine. Its maximum tolerated dose (MTD) was determined from a safety perspective in a combination study with capecitabine; however, its inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Hikari, Takenaka, Toru, Takahashi, Koichi, Yamashita, Fumiaki, Matsuoka, Kazuaki, Yoshisue, Kunihiro, Ieiri, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124359/
https://www.ncbi.nlm.nih.gov/pubmed/34951129
http://dx.doi.org/10.1002/psp4.12747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124359/
https://www.ncbi.nlm.nih.gov/pubmed/34951129
http://dx.doi.org/10.1002/psp4.12747

Ejemplares similares